Difficulty: Medium
Average Score: 83%
Practice
Chemotherapy has a major role in many childhood CNS tumors. In which of the following tumors is chemotherapy not effective?
Correct answer
A
Rationale
Chemotherapy is a crucial treatment modality for many childhood CNS tumors, but its effectiveness varies depending on the tumor type. In the case of pilocytic astrocytoma, it is typically considered a low-grade tumor with a well-defined structure, making it more amenable to surgical resection and less responsive to chemotherapy. This tumor usually has a good prognosis with surgery alone.
Craniopharyngioma, pineoblastoma, and SPNETs are more aggressive tumors that often require a multimodal treatment approach involving surgery, chemotherapy, and radiation. Chemotherapy plays a significant role in targeting the rapidly dividing cancer cells in these types of tumors, helping to reduce tumor size, prevent recurrence, and improve overall outcomes.
Educationally, understanding the varying responses of different CNS tumors to chemotherapy is essential for healthcare providers involved in the care of pediatric oncology patients. It highlights the importance of individualized treatment plans based on tumor characteristics and guides discussions with families regarding treatment expectations and potential outcomes. This knowledge empowers healthcare professionals to provide optimal care and support to pediatric patients and their families facing CNS tumors.
Craniopharyngioma, pineoblastoma, and SPNETs are more aggressive tumors that often require a multimodal treatment approach involving surgery, chemotherapy, and radiation. Chemotherapy plays a significant role in targeting the rapidly dividing cancer cells in these types of tumors, helping to reduce tumor size, prevent recurrence, and improve overall outcomes.
Educationally, understanding the varying responses of different CNS tumors to chemotherapy is essential for healthcare providers involved in the care of pediatric oncology patients. It highlights the importance of individualized treatment plans based on tumor characteristics and guides discussions with families regarding treatment expectations and potential outcomes. This knowledge empowers healthcare professionals to provide optimal care and support to pediatric patients and their families facing CNS tumors.